29 October 2021 – EMBO Member Adriano Aguzzi is the Director of the Institute of Neuropathology at the University of Zurich. The Aguzzi lab investigates the molecular basis of prion diseases and other neurodegenerative illnesses. We spoke with Adriano Aguzzi and Review Commons project leader Thomas Lemberger about preprints, peer review, paying for innovation in publishing, and an unexpected positive control.
From prions to preprints
An interview with neuropathologist Adriano Aguzzi
Recent episodes and related news
Read more >
An interview with Stephen Quake